Stock & Company Details
Arbutus Biopharma Corp $ABUS
Price:
N/A
N/A
153M
$624M
52 Week High:
N/A
10 Day Average Volume:
N/A
5.20
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ABUS technical indicators
Latest Arbutus Biopharma Corp (ABUS) indicator readings as of 2026-11-19.
ABUS's 14-day RSI is 48.0, in neutral territory. ADX reads 23.2, sitting between trending and range-bound. MACD (12, 26, 9) is -0.08, below the zero line.
Overview
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. It is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.
Finance Bot
Ask your questions
Start by typing a question below.